Clearance Summary
CEFALY received FDA 510(k) clearance under submission number DEN120019, sponsored by Stx-Med Sprl. The device was reviewed via the Post-NSE premarket notification pathway and assigned to the Neurology review panel. The statutory decision date of record is 2014-03-11.
- Submission: DEN120019
- Applicant / Sponsor: Stx-Med Sprl
- Clearance pathway: Post-NSE
- Review panel: Neurology
- Device class: Class II
- Regulation citation: 21 CFR 882.5891
- Decision date: 2014-03-11
Classification & Regulation
This clearance is catalogued under FDA product code PCC and 21 CFR 882.5891, within the Neurology review panel as a Class II device.